Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists

被引：14

作者：

Chu, Guo-Hua ^{[1
]}

Saeui, Christopher T. ^{[1
]}

Worm, Karin ^{[1
]}

Weaver, Damian G. ^{[1
]}

Goodman, Allan J. ^{[1
]}

Broadrup, Robert L. ^{[1
]}

Cassel, Joel A. ^{[2
]}

DeHaven, Robert N. ^{[2
]}

LaBuda, Christopher J. ^{[2
]}

Koblish, Michael ^{[2
]}

Brogdon, Bernice ^{[3
]}

Smith, Steve ^{[3
]}

Le Bourdonnec, Bertrand ^{[1
]}

Dolle, Roland E. ^{[1
]}

机构：

[1] Adolor Corp, Dept Chem, Exton, PA 19341 USA

[2] Adolor Corp, Dept Pharmacol, Exton, PA 19341 USA

[3] Adolor Corp, Dept DMPK, Exton, PA 19341 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 20期

关键词：

Cannabinoid receptors; Selective CB2 agonists; Pain; Pyridine derivatives; PAIN; BINDING; ACTIVATION; DISCOVERY; RAT;

D O I：

10.1016/j.bmcl.2009.08.063

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Replacement of the phenyl ring in our previous ( morpholinomethyl) aniline carboxamide cannabinoid receptor ligands with a pyridine ring led to the discovery of a novel chemical series of CB2 ligands. Compound 3, that is, 2,2-dimethyl-N-(5-methyl-4-(morpholinomethyl)pyridin-2-yl)butanamide was identified as a potent and selective CB2 agonist exhibiting in vivo efficacy after oral administration in a rat model of neuropathic pain. (C) 2009 Elsevier Ltd. All rights reserved.

引用

收藏

页码：5931 / 5935

页数：5

相关论文

共 13 条

[1] Arylsulfonamide CB2 receptor agonists:: SAR and optimization of CB2 selectivity [J].

Ermann, Monika ;

Riether, Doris ;

Walker, Edward R. ;

Mushi, Innocent F. ;

Jenkins, James E. ;

Noya-Marino, Beatriz ;

Brewer, Mark L. ;

Taylor, Malcolm G. ;

Amouzegh, Patricia ;

East, Stephen P. ;

Dymock, Brian W. ;

Gemkow, Mark J. ;

Kahrs, Andreas F. ;

Ebneth, Andreas ;

Loebbe, Sabine ;

O'Shea, Kathy ;

Shih, Daw-Tsun ;

Thomson, David .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (05) :1725-1729

[2] Discovery of 2-[(2,4-Dichlorophenyl)amino]-N-[(tetrahydro-2H-pyran-4-yl)methyl]-4-(trifluoromethyl)-5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain [J].

Giblin, Gerard M. P. ;

O'Shaughnessy, Celestine T. ;

Naylor, Alan ;

Mitchell, William L. ;

Eatherton, Andrew J. ;

Slingsby, Brian P. ;

Rawlings, D. Anthony ;

Goldsmith, Paul ;

Brown, Andrew J. ;

Haslam, Carl P. ;

Clayton, Nick M. ;

Wilson, Alex W. ;

Chessell, Iain P. ;

Wittington, Andrew R. ;

Green, Richard .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (11) :2597-2600

[3] Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin [J].

Hohmann, AG ;

Farthing, JN ;

Zvonok, AM ;

Makriyannis, A .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02) :446-453

[4] CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids [J].

Ibrahim, MM ;

Porreca, F ;

Lai, J ;

Albrecht, PJ ;

Rice, FL ;

Khodorova, A ;

Davar, G ;

Makriyannis, A ;

Vanderah, TW ;

Mata, HP ;

Malan, TP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (08) :3093-3098

[5] Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat [J].

LaBuda, CJ ;

Little, PJ .

JOURNAL OF NEUROSCIENCE METHODS, 2005, 144 (02) :175-181

[6] CB2 cannabinoid receptor agonists:: pain relief without psychoactive effects? [J].

Malan, TP ;

Ibrahim, MM ;

Lai, J ;

Vanderah, TW ;

Makriyannis, A ;

Porreca, F .

CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (01) :62-67

[7] PHOSPHORUS IN ORGANIC SYNTHESIS .7. DIPHENYL PHOSPHORAZIDATE (DPPA) - NEW CONVENIENT REAGENT FOR A MODIFIED CURTIUS REACTION [J].

NINOMIYA, K ;

SHIOIRI, T ;

YAMADA, S .

TETRAHEDRON, 1974, 30 (14) :2151-2157

[8]

Obach RS, 1999, DRUG METAB DISPOS, V27, P1350

[9] Modulation of pain transmission by G-protein-coupled receptors [J].

Pan, Hui-Lin ;

Wu, Zi-Zhen ;

Zhou, Hong-Yi ;

Chen, Shao-Rui ;

Zhang, Hong-Mei ;

Li, De-Pei .

PHARMACOLOGY & THERAPEUTICS, 2008, 117 (01) :141-161

[10]

PINTO JC, 1994, MOL PHARMACOL, V46, P516